Genmab — Februar 2019
-
norsk vavaccine
-
vaccine
-
Biotech Outlook 2019 fra Loncar. Manden er pjattet med Bispecific https://www.pscp.tv/w/1eaKbOpjlbjGX?t=56s
-
dejligt at den kan klare sig over 1000 med den lave volumen. I går var vist en enlig svale
-
Pæn stor blok i 1002.
-
Den røg så lidt højere op.
-
Denne mail indeholder data fra et abonnement på indberetninger på OASM systemet hos Finanstilsynet.
Marshall Wace LLP has reduced his short position to 303580 shares issued by Genmab A/S
14.02.19 13:32:14
Genmab A/S
Shortselling
Vis meddelelse -
Måske forklaring
-
Det kunne forklare stigningen i går.
-
de har reduceret med 10k aktier
-
Ok. De har langt igen.
-
men 300k aktier er da stadig en position, hvis upside risk skulle materialisere sig
-
De er nok også købere fremad
-
Ja de må gerne klemmes lidt
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind